PUNE, India, October 15, 2015 /PRNewswire/ --
According to the new Market Research Report "Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] - Global Forecast to 2019", the Global Intrauterine Contraceptive Devices report defines and segments the concerned market with analysis and forecast of revenue. This market is estimated to grow around $3,655.5 million by 2019, at a developing CAGR of 3.3% from 2014 to 2019.
Browse through the TOC of the Global Intrauterine Contraceptive Devices market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures.
Early buyers will receive 10% customization on this report.
Intrauterine device (IUCD) is a small contraceptive device that is inserted into the uterus to prevent pregnancy. The IUCDs are available in two types: the copper and hormonal IUCD. The hormonal IUCD contains progesterone, which is a synthetic version of the naturally occurring hormone progesterone. Both these types are very effective methods of contraception and can stay in place for an average of at least five years.
The major drivers behind the growing intrauterine contraceptive devices market include increasing rate of unplanned pregnancies, effective contraceptive method, and less side effects as compared to other contraceptive methods. In the U.S, 82.0% of the adolescent pregnancies are unplanned, accounting for one-fifth of all unintended pregnancies. The users, especially adolescents trust the intrauterine devices market, as it is extremely reliable and effective. As a result, long-acting reversible contraception (LARC) methods, such as intrauterine contraceptive devices are adopted on a large scale.
For more Inquiries: http://www.micromarketmonitor.com/contact/9403617870-inquery_before_buy.html
Key Players of the Global Intrauterine Contraceptive Devices Market include:
Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland)
Asia contributed maximum towards global intrauterine contraceptive devices market registered 51.2% of market share in 2014.
IUCD is safe and more effective than other contraceptives, such as oral contraceptives, as the other contraceptives have several side effects, such as dizziness, headache, lightheadedness, stomach upset, bloating, or nausea.
This market is segmented and forecast on the basis of different type and products. There are two major types of IUCDs, namely copper and hormonal IUCD. The marketed products in the purview of this report are: Mirena, Skyla, Paragard, Liletta, and few pipeline products. The market is further segmented and forecast on the basis of major regions, such as the Asia, Europe, North America, and Rest of the World (RoW).
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Email: [email protected]
SOURCE MicroMarket Monitor